BOSTON--(BUSINESS WIRE)--Ensoma, an in vivo hematopoietic stem cell (HSC) engineering company with a mission to advance the future of medicine through one-time therapies, today announced the closing ...

Funded by the UB Provost, the new Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis. “I am very happy to announce the launch of the Cell ...

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...

The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans ...

Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...